SCHEMBL6023942

SCHEMBL6023942

CC(C)(C)c1cc(CN2CCN(c3ccc(N=C(N)c4ccc[nH]4)cc3)CC2)cc(C(C)(C)C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 4/20 0.47
MAPT P10636 3/20 0.47
GAA P10253 4/20 0.45
TSHR P16473 3/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
THRB P10828 1/20 0.45
HPGD P15428 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 1/20 0.42
KCNH2 Q12809 1/20 0.38
DRD4 P21917 2/20 0.37
MAOB P27338 3/20 0.37
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
ADRA2A P08913 2/20 0.36
ADRA2B P18089 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4310929 0.82 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTGAATSHR
Hydrochloric Acid SCHEMBL4315282 0.82 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL6022707 0.81 ALDH1A1 (0.39) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL7033277 0.80 MAPT (0.37) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL6023941 0.80 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL6022745 0.78 ME2 (0.43) ALDH1A1KDM4EMAPTGAALMNA
SCHEMBL4320476 0.77 ALDH1A1 (0.63) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL8843893 0.76 ALDH1A1 (0.67) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL9417094 0.71 ALDH1A1 (0.90) ALDH1A1KDM4EMAPTGAATSHR
SCHEMBL4318947 0.70 POLB (0.58) ALDH1A1KDM4EMAPTGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 ALDH1A1 804/4885KDM4E 1388/4885MAPT 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.